Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Dr. Meltzer is studying molecular biomarkers that are able to identify Barrett’s Esophagus and indicate when a patient is likely to develop esophageal cancer.
More Articles on Gastroenterology:
8 Gastroenterology Devices Receive FDA 510(k) Clearance in March
ResearchMoz Releases Endosocpy Market Outlook Report
6 Steps to Keep GI-Driven Surgery Center Patients Safer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
